A5046164331- Bariatric Surgery and Outcomes
- Obesity and Health Practices
- Diet and metabolism studies
- Obesity, Physical Activity, Diet
- Body Contouring and Surgery
- Clinical Nutrition and Gastroenterology
- Cardiac, Anesthesia and Surgical Outcomes
- Nutrition and Health in Aging
- Pharmacology and Obesity Treatment
- Gastroesophageal reflux and treatments
- COVID-19 and healthcare impacts
- Intestinal and Peritoneal Adhesions
- Surgical Simulation and Training
- Esophageal and GI Pathology
- Hernia repair and management
- Child and Adolescent Health
- Cardiovascular Function and Risk Factors
- Child Nutrition and Feeding Issues
- Diabetes Treatment and Management
- Abdominal Surgery and Complications
- Stoma care and complications
- Alcoholism and Thiamine Deficiency
- Eating Disorders and Behaviors
- Surgical Sutures and Adhesives
- Patient-Provider Communication in Healthcare
Stanford University
2017-2024
VA Palo Alto Health Care System
2020-2024
Lucile Packard Children's Hospital
2017-2024
Stanford Medicine
2019-2023
American Society for Metabolic and Bariatric Surgery
2011-2022
Palo Alto University
2020
University of Arizona
2018
University of Florida
2018
Dermatology Specialists
2018
RELX Group (United States)
2018
Major updates to 1991 National Institutes of Health guidelines for bariatric surgery.
MAJOR UPDATES TO 1991 NATIONAL INSTITUTES OF HEALTH GUIDELINES FOR BARIATRIC SURGERY: Metabolic and bariatric surgery (MBS) is recommended for individuals with a body mass index (BMI) >35 kg/m2, regardless of presence, absence, or severity co-morbidities.MBS should be considered metabolic disease BMI 30-34.9 kg/m2.BMI thresholds adjusted in the Asian population such that >25 kg/m2 suggests clinical obesity, >27.5 offered MBS.Long-term results MBS consistently demonstrate safety...
Context: Bariatric surgery is increasingly popular but may lead to metabolic bone disease. Objective: The objective was determine the rate of loss in 24 months after Roux-en-Y gastric bypass. Design and Setting: This a prospective cohort study conducted at an academic medical center. Participants: participants were adults with severe obesity, including 30 undergoing bypass 20 nonsurgical controls. Outcomes: We measured mineral density (BMD) lumbar spine proximal femur by quantitative...
Abstract Metabolic and bariatric surgery (MBS) is widely considered the most effective option for treating obesity, a chronic, relapsing, progressive disease. Recently, American Society of Bariatric Surgery (ASMBS) International Federation Obesity Disorders (IFSO) issued new guidelines on indications MBS, which have superseded previous 1991 National Institutes Health guidelines. The aim this study to establish first set consensus selecting procedures in Class I II using an Expert Modified...
This paper presents a retrospective cohort study of weight loss medications in young adults aged 21 to 30 following Roux-en-Y gastric bypass (RYGB) and sleeve gastrectomy (SG) between November 2000 June 2014. Data were collected from patients who used topiramate, phentermine, and/or metformin postoperatively. Percentage achieving ≥5%, ≥10%, or ≥15% on was determined percent change each medication compared the rest cohort. Our results showed that 54.1% lost ≥5% their postsurgical weight;...
We sought to compare the short and long-term outcomes of MBS in adolescents vs. adults who have undergone a Roux-en-Y gastric bypass (RYGB) or Sleeve gastrectomy (SG).
OBJECTIVES: In this report, we compare weight loss, comorbidity resolution, nutritional abnormalities, and quality of life between younger older adolescents after metabolic bariatric surgery. METHODS: From March 2007 to December 2011, 242 (≤19 years age) who underwent surgery at 5 clinical centers in the United States were enrolled prospective, multicenter, long-term outcome study Teen–Longitudinal Assessment Bariatric Surgery. Outcome data from (13–15 years; n = 66) (16–19 162) participants...
To update evidence-based best practice guidelines for obtaining informed consent from weight loss surgery (WLS) patients, with an emphasis on appropriate content and communications approaches that might enhance patient understanding of the information, we performed a systematic search English-language literature published between April 2004 May 2007 in MEDLINE Cochrane database. Keywords included WLS consent, comprehension, health literacy, education; outcomes, risk, safety management,...
Obesity is prevalent among adolescents and associated with serious health consequences. Roux-en-Y Gastric Bypass (RYGB) Sleeve Gastrectomy (SG) are bariatric procedures that cause significant weight loss in adults increasingly being performed morbid obesity. Data comparing outcomes of RYGB vs. SG this age-group scarce. This study aims to compare short-term (1-6 months) longer-term (7-18 body mass index (BMI) biochemical following adolescents/young adults.A retrospective using data extracted...
Weight loss medications are effective to confer additional weight after bariatric surgery in the general population, but they have not been evaluated adults 60 years of age and older. We performed a retrospective study identifying 35 patients who were ≥60 old had undergone Roux-en-Y gastric bypass (RYGB) or sleeve gastrectomy (SG) from 2000 2014, subsequently prescribed medications. Linear regression analyses determine beta coefficients certain predictor variables being associated with loss....